Jaguar Health (JAGX) Goodwill (2017 - 2018)

Jaguar Health's (JAGX) quarterly Goodwill came in at $5.2 million in Q4 2018, little changed year-on-year from $5.2 million in Q4 2017, and little changed on a QoQ basis from $5.2 million in Q3 2018.

Jaguar Health (JAGX) Goodwill (2017 - 2018) Analysis & Trends

Jaguar Health (JAGX) has 2 years of Goodwill data on file, last reported at $5.2 million in Q4 2018.

  • On a quarterly basis, Goodwill changed 0.0% year-over-year to $5.2 million in Q4 2018; TTM through Dec 2018 was $5.2 million, a 0.0% change from a year earlier, with the FY2018 full-year figure at $5.2 million, changed 0.0% from the prior year.
  • Goodwill for Q4 2018 stood at $5.2 million, roughly flat from $5.2 million in the prior quarter.
  • Over the last five years, Goodwill for JAGX reached as high as $18.4 million in Q3 2017 and fell as low as $5.2 million in Q4 2017.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Nanobiotix 1,782.24 Bn 1,782.18 Bn -
2 Akari Therapeutics 1,009.43 Bn 1,009.43 Bn -
3 BeOne Medicines 473.46 Bn 468.66 Bn 1.35 Bn
4 Vertex Pharmaceuticals 123.84 Bn 116.59 Bn 2.59 Bn
5 Regeneron Pharmaceuticals 71.69 Bn 62.94 Bn 3.31 Bn
6 Belite Bio 62.15 Bn 62.15 Bn -
7 Argenx Se 54.74 Bn 49.55 Bn 1.41 Bn
8 Alnylam Pharmaceuticals 38.08 Bn 35.07 Bn 959.66 Mn
9 Revolution Medicines 36.07 Bn 36.07 Bn -
10 Jaguar Health 520,945.88 -9.54 Mn 19.11 Mn

Historic Data

Download Data
DateValue
Dec 31, 2018 5.21 Mn
Sep 30, 2018 5.21 Mn
Jun 30, 2018 5.21 Mn
Mar 31, 2018 5.21 Mn
Dec 31, 2017 5.21 Mn
Sep 30, 2017 18.39 Mn